Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
10/2003
10/23/2003US20030199017 Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2478392A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/22/2003EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes
10/22/2003EP1353959A1 Surface-active photoinitiators
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353673A1 Camptothecin derivatives
10/22/2003EP1235822B1 Tocotrienols and geranylgeraniol from bixa orellana byproducts
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451001A Chromanone derivatives
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450063A Process of supercritical carbon dioxide extracting licoflavone
10/22/2003CN1450062A Coumarin group compound, synthesis process and use thereof
10/22/2003CN1450061A Process for extracting Isofraxidin
10/22/2003CN1450060A Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi
10/22/2003CN1450051A Amino acid derivatives and their use as pesticides
10/22/2003CN1450044A Process for preparation of bicyclic diketone salts
10/22/2003CN1449761A Medicine for relieving spasm and pain and preparation process thereof
10/22/2003CN1125029C Preparation process of acetate
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635772 Reacting dialkylphenol, formaldehyde and alcohol in presence of secondary amine and acid
10/21/2003US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084946A1 Production of dihydronepetalactone by hydrogenation of nepetalactone
10/16/2003WO2003084945A1 An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003064407A3 Production of δ9 tetrahydrocannabinol
10/16/2003WO2002060887A3 Synthesis of 4h-chromene derivatives
10/16/2003US20030195340 Chromene compound
10/16/2003US20030195245 Administering prodrugs of metabolites such as 5-methyl-7-ethyl carbonate-isoflavone, to increasing concentration of flavonoids
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula
10/15/2003EP1352907A1 Processes for preparing calanolide a and intermediates thereof
10/15/2003EP1352905A1 Flavanol and cysteamine conjugates
10/15/2003EP1352890A1 Process for the preparation of bicyclic diketone salts
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists
10/15/2003CN1449393A Intermediates for use in the preparation of vitamin e
10/15/2003CN1448395A Antioxidant EGCG aliphatic ester and prep. thereof
10/15/2003CN1448394A Method for extracting soybean isoflavone from soya bean watse
10/15/2003CN1124271C Process for preparing coumarin sulfonates
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/09/2003WO2003082849A1 Chromene compound
10/09/2003WO2003045328A3 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
10/09/2003WO2003022994A3 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
10/09/2003US20030191348 Such as 5-methyl-3-phenyl)-inden-1-one for enantioselective preparation of tolterodine and analogues/salts thereof
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191047 Fragrance compound
10/09/2003US20030190680 Photocleavable bioreactive agents
10/08/2003EP1141137B1 Water-soluble rhodamine dyes and conjugates thereof
10/08/2003EP1123304B1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1447685A Process for decreasing cell proliferation based on (3R,4R)-Ôû�8-tetrahydrocannabinol)-11-acid
10/08/2003CN1446810A Technique for separating monomer flavone from general flavone and its products
10/07/2003US6630597 Photochromic 6-aryl substituted 3H-naphtho(2,1-b)pyrans
10/07/2003US6630508 Substituted benzopyrans as selective estrogen receptor β agonists
10/07/2003US6630507 Cannabinoids as antioxidants and neuroprotectants
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2261267C Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003WO2003080778A2 Methods for treating deodorizer distillate
10/02/2003WO2003080595A1 Blue 3h-naphtho-[2,1-b]-pyran derivatives and use thereof
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080593A1 Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
10/02/2003WO2003080555A1 Process for producing chromone compound
10/02/2003WO2003079998A2 Treatment of diseases involving defective gap junctional communication
10/02/2003WO2003079965A2 Derivatives of isoflavones
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187015 Viricides; anticancer agents
10/02/2003US20030187012 Reduction physical cigarette smoking
10/02/2003US20030186975 Coumarin derivatives with comt inhibiting activity
10/02/2003US20030186448 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis
10/02/2003US20030186349 Optical molecular sensors for cytochrome P450 activity
10/02/2003CA2479773A1 Methods for treating deodorizer distillate
10/02/2003CA2479555A1 Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients
10/02/2003CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003CN1446053A Food supplement
10/01/2003CN1446052A Improved method for extracting cocoa procyanidins
10/01/2003CN1445223A Method for preparing EGCG mono fatty acid ester by using high-speed countercurrent chromatographic separation
10/01/2003CN1445222A Benzofuran category compound, its preparing method and usage
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
09/2003
09/30/2003US6627232 Multistage solvent extraction with ethyl acetate, acetone, water and ethanol
09/30/2003US6627121 Photochromic naphthopyran compounds
09/30/2003US6627111 Reduced pH sensitivity and enhanced stability to protonation; efficiency
09/25/2003WO2003077904A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
09/25/2003WO2003077832A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003US20030180406 Treatment of diseases involving defective gap junctional communication
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 242